Propionic Acid

Propionic Acid

SCHEMBL4160185

CCC(=O)O.CCNc1nccc(-c2ccc3[nH]c(=O)c4[nH]ccc4c3c2)n1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 2/20 0.47
CLK1 P49759 3/20 0.36
CLK2 P49760 3/20 0.36
DYRK1A Q13627 3/20 0.36
CLK4 Q9HAZ1 3/20 0.36
DYRK1B Q9Y463 3/20 0.36
CLK3 P49761 2/20 0.36
IDH1 O75874 2/20 0.35
JUN P05412 2/20 0.35
MAPK8 P45983 2/20 0.35
MAPK9 P45984 2/20 0.35
AKT3 Q9Y243 1/20 0.35
MAPK10 P53779 1/20 0.35
AURKA O14965 2/20 0.35
TTK P33981 2/20 0.35
AURKB Q96GD4 2/20 0.35
INCENP Q9NQS7 2/20 0.35
PIK3CA P42336 1/20 0.35
PIM1 P11309 1/20 0.35
PIM2 Q9P1W9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4169954 0.91 AURKA (0.43) PDPK1IDH1JUNMAPK8MAPK9
Propionic Acid SCHEMBL4161183 0.88 JAK2 (0.47) MAPK8MAPK10PIK3CASPHK1
Propionic Acid SCHEMBL4160216 0.88 AURKA (0.41) PDPK1IDH1JUNMAPK8MAPK9
Propionic Acid SCHEMBL4157712 0.85 CDK2 (0.41) PDPK1CLK4AURKAAURKBPIM1
Propionic Acid SCHEMBL4159507 0.85 PDPK1 (0.42) PDPK1DYRK1APIM1PIM2SPHK1
Propionic Acid SCHEMBL4161864 0.84 ABL1 (0.37) IDH1MAPK8MAPK10AURKAAURKB
SCHEMBL3245517 0.80 PDPK1 (0.46) PDPK1CLK1CLK2DYRK1ACLK4
SCHEMBL4160172 0.79 PDPK1 (0.43) PDPK1CLK1CLK2DYRK1ACLK4
SCHEMBL4713573 0.79 PIK3C3 (0.49) MAPK8SPHK1EIF2AK2
Propionic Acid SCHEMBL4153840 0.78 PIM1 (0.44) PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PDPK1 23/4885CLK1 776/4885CLK2 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.